Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 6/20 | 0.60 |
| ▸ | BCR | P11274 | 6/20 | 0.60 |
| ▸ | EPHB4 | P54760 | 2/20 | 0.49 |
| ▸ | BRAF | P15056 | 11/20 | 0.48 |
| ▸ | RAF1 | P04049 | 1/20 | 0.48 |
| ▸ | BTK | Q06187 | 1/20 | 0.45 |
| ▸ | JAK2 | O60674 | 1/20 | 0.44 |
| ▸ | CSF1R | P07333 | 1/20 | 0.44 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.44 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.44 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29071512 | 1.00 | ABL1 (0.60) | ABL1BCREPHB4BRAFRAF1 | |
| SCHEMBL29921892 | 0.92 | ABL1 (0.72) | ABL1BCREPHB4BRAFRAF1 | |
| SCHEMBL29071349 | 0.92 | ABL1 (0.72) | ABL1BCREPHB4BRAFRAF1 | |
| SCHEMBL29921965 | 0.89 | ABL1 (0.51) | ABL1BCRBRAFRAF1CSF1R | |
| SCHEMBL29071235 | 0.89 | ABL1 (0.51) | ABL1BCRBRAFRAF1CSF1R | |
| SCHEMBL29071240 | 0.89 | ABL1 (0.59) | ABL1BCRBRAFRAF1CSF1R | |
| SCHEMBL29921674 | 0.89 | ABL1 (0.59) | ABL1BCRBRAFRAF1CSF1R | |
| SCHEMBL29921912 | 0.86 | ABL1 (0.56) | ABL1BCRBRAFRAF1BTK | |
| SCHEMBL29921279 | 0.85 | ABL1 (0.63) | ABL1BCREPHB4BRAFRAF1 | |
| SCHEMBL29071524 | 0.85 | ABL1 (0.63) | ABL1BCREPHB4BRAFRAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116761801-A | Heterocyclic compounds having protein kinase inhibitory activity, pharmaceutical compositions containing the same, and methods of preparing and using the same | 四川科伦博泰生物医药股份有限公司 | 2023-09-15 | — | — | CN | disclosed |
| WO-2022188792-A1 | HETEROCYCLIC COMPOUND HAVING PROTEIN KINASE INHIBITORY ACTIVITY, PHARMACEUTICAL COMPOSITION COMPRISING SAME, PREPARATION METHOD THEREFOR, AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2022-09-15 | — | — | WO | disclosed |